LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1HRV Global Life Sciences
03 1ACS DOBFAR SPA
04 1Asymchem Laboratories
05 1Aurobindo Pharma Limited
06 1Beijing Lunarsun Pharmaceutical Co., Ltd
07 1CSPC Pharmaceutical Group
08 1GLAND CHEMICALS PRIVATE LIMITED
09 1GLAND PHARMA LIMITED
10 1Guangzhou Tosun Pharmaceutical
11 1High Science Co., Ltd
12 1Hospira, Inc.
13 1JILIN ASYMCHEM LABORATORIES CO LTD
14 1JW Pharmaceutical Corporation
15 1Jeil Pharmaceutical Co., Ltd
16 1Kaliberr Labs
17 1Kopran
18 1Qilu Antibiotics Pharmaceutical Co., Ltd.
19 1Qilu Pharmaceutical
20 1Savior Lifetec Corporation
21 1Shandong Anhong Pharmaceutical
22 1Solara Active Pharma Sciences
23 1Sun Pharmaceutical Industries Limited
24 1Tecoland Corporation
25 1Zhejiang Hisoar Pharmaceutical
01 8China
02 8India
03 1Italy
04 2South Korea
05 2Taiwan
06 4U.S.A
01 9Active
02 2Inactive
03 14Blank
01 25Blank
01 25Blank
01 25Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28391
Submission : 2014-06-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37463
Submission : 2023-03-02
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-04-20
Pay. Date : 2018-01-11
DMF Number : 32424
Submission : 2018-01-12
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40191
Submission : 2024-09-13
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-09-30
Pay. Date : 2022-08-19
DMF Number : 37232
Submission : 2022-08-29
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-02-25
Pay. Date : 2015-12-30
DMF Number : 30123
Submission : 2016-01-07
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-03-03
Pay. Date : 2016-08-22
DMF Number : 30709
Submission : 2016-05-19
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 27348
Submission : 2013-09-24
Status : Inactive
Type : II
A Ertapenem Sodium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ertapenem Sodium, including repackagers and relabelers. The FDA regulates Ertapenem Sodium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ertapenem Sodium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ertapenem Sodium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ertapenem Sodium supplier is an individual or a company that provides Ertapenem Sodium active pharmaceutical ingredient (API) or Ertapenem Sodium finished formulations upon request. The Ertapenem Sodium suppliers may include Ertapenem Sodium API manufacturers, exporters, distributors and traders.
click here to find a list of Ertapenem Sodium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 25 companies offering Ertapenem Sodium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?